menu search

Revolut expands super app with robo advisor launch in us

Revolut, a London-based neobank, has expanded its suite of products and services by introducing a robo-...

June 29, 2023, 7:36 pm

Regeneron to report second quarter 2023 financial and operating results and host conference call and webcast on august 3, 2023

TARRYTOWN, N.Y., June 29, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quart...

June 29, 2023, 4:01 pm

Cybin narrows net loss year-over-year; eyes fda submission in late 2023

Cybin Inc. (NYSE-A:CYBN, neo:CYBN) reported that it has narrowed its net loss year-over-year as it has ...

June 29, 2023, 10:08 am

Qatari bid edges closer to manchester united takeover, reports

The Qatari bid for Manchester United is said to be edging closer, according to latest reports. Bloomberg, which cites sources familiar with the matter...

June 29, 2023, 8:05 am

Alert: the m&a class action firm continues investigating the merger – synh, aaic, prtk, nex

NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) — Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the �...

June 29, 2023, 2:35 am

Atossa therapeutics hits 30% enrollment for (z)-endoxifen arm of ongoing i-spy 2 clinical trial

Atossa Therapeutics Inc (NASDAQ:ATOS), which is developing medicines aimed at oncology and breast cancer, revealed that six patients have been dosed w...

June 28, 2023, 11:01 am

Spyi crosses $100 million as investors flood into s&p 500

Investors flocked to broad equities in the last week as market volatility continues. The neoS S&P 500 H...

June 27, 2023, 5:15 pm

Naspers limited (npsny) q4 2023 earnings call transcript

Naspers Limited (OTCPK:NPSNY) Q4 2023 Earnings Conference Call June 27, 2023 10:00 AM ET Company Participants Eoin Ryan - IR Bob van Dijk - CEO Basil ...

June 27, 2023, 3:25 pm

Syneos health (synh) collaborates with umotif for new platform

Syneos Health (SYNH) partners with uMotif to deliver the patient-centric eClinical platform....

June 27, 2023, 9:03 am

Additional oneok-magellan deal details disclosed in sec filings

Recent regulatory filings from OneoK (OKE) and Magellan Midstream Partners, LP (MMP) provide insight in...

June 26, 2023, 4:37 pm

Monday.com: healthy free cash flow and ~$950m cash with no long-term debt

monday.com Ltd. is a holistic software platform that resembles a young Atlassian Corporation or Salesforce, Inc. It offers a variety of products, incl...

June 26, 2023, 2:38 pm

Canada may advance wholesale trade +3.5%

Advance manufacturing sales +0.8%That's a strong number on wholesale trade and was led by Motor vehicles and motor vehicle parts and accessories: +7.4...

June 26, 2023, 12:36 pm

Reneo pharmaceuticals added to russell 2000® and russell 3000® indices

IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinic...

June 26, 2023, 12:25 pm

Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br

– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...

June 24, 2023, 9:01 am

Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br

– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...

June 24, 2023, 9:01 am

Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br

– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...

June 24, 2023, 9:01 am

Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br

– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...

June 24, 2023, 9:01 am

Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br

– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...

June 24, 2023, 9:01 am

Data from 89bio’s enliven phase 2b trial of pegozafermin in patients with nonalcoholic steatohepatitis (nash) published in the new england journal of medicine and simultaneously presented in a late-br

– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted in statistically significant chan...

June 24, 2023, 9:01 am

Under the hood of cshi, a cash alternative etf

Markets look to end a multiple-week winning streak this week as recession fears and aggressive Fed talk weigh heavily on investors. For those looking ...

June 23, 2023, 5:03 pm


Search within

Pages Search Results: